Sary To establish whether p53 mutation precedes or follows clonal divergence in human colorectal carcinomas, 17 tumours were analysed at multiple sites (2-5 each) for single-strand conformation polymorphisms (SSCP) within exons 5-8 of the p53 gene. A previous study had demonstrated subclones of differing DNA pkoidy in these tumours, but all showed immunocytochemical evidence for p53 stabilisation, using the monockal antibody PAb 1801. Mutations within exons 5-8 of p53 were identified by the presence of an abnormally migrating band in 10 of the 17 carcinomas: five in exon 5, four in exon 7 and one in exon 8. In each of these positive cases samples from different parts of the cacino showed identiclW gd migration patterns in SSCP analysis. Similarly, the rm_ainin seven tumours were concordant for absence of band shift across all samples of each tumour. Six SSCP-positive cases contained multiple populations differing in DNA ploidy, while four were homogeneously diploid or aneuploid throughout. Very similar proportions were observed in the SSCP-negtive cases. In four positive tumours the mutation was confirmed by sequencing or through alteration of nucleotide-specific restriction enzyme cleavage. Identical mutations appeared in every sample from the same tumour. The results provide unequivocal evidnce that the same mutant allele of p53 is present throughout each tumour bearing a mutation, regardless of the clonal variation identified by analysis of DNA ploidy. We conclude that in colorectal tumorigenesis mutation of p53 occurs as a single event which precedes and may facilitate the aneuploid clonal divergence of carcinomas.
Inactivation of the tumour-suppressor gene p53 is an important step in the development of the majority of human cancers (Hollstein et al., 1991) . Functional inactivation occurs most commonly as a result of missense mutation (Baker et al., 1989) but can also result from interaction with oncogenic viral or cellular proteins (Mietz et al., 1992; Momand et al., 1992) . The p53 protein is a sequence-specific DNA-binding protein that is active as a transcription factor (Bargonetti et al., 1991) and can interact directly with the replication apparatus (Dutta et al., 1993) . There is good evidence that its normal function is to establish GI checkpoint control in response to DNA damage, so allowing time for DNA repair (Kastan et al., 1991) or the initiation of apoptosis (Clarke et al., 1993) . Lack of functional p53 promotes genomic instability (Bischoff et al., 1990; Harvey et al., 1993) , which is probably a key factor in acquisition of the multiple 'hits' required for carcinogenesis (Nowell, 1976) .
We have recently shown that human colorectal carcinomas containing immunohistochemically detectable p53 are more likely to contain multiple aneuploid DNA stem lines than those which are p53 negative (Carder et al., 1993) . This result is in keeping with a relationship between p53 and genomic instability. We also reported that in carcinomas containing stabilised p53 the abnormality was almost always present throughout the tumour even though DNA analysis revealed the presence of divergent stem lines. From these findings we concluded that p53 stabilisation is a critical early event in cancer evolution favouring the development of tetraploid and other aneuploid sublines. Since it is now clear that p53 stabilisation can be the result of the tumour cell environment, independent of mutation (Vojtsek and Lane, 1993) , we felt it was important to re-examine these cases for more definitive evidence, firstly, that mutation of p53 had occurred and, secondly, that it preceded clonal divergence in tumour progression. To this end we used the technique of singlestranded conformation polymorphism (SSCP) analysis (Orita et al., 1989; Glavac and Dean, 1993) 
Samples
Sixty-four samples from 17 colorectal carcinomas from our previously published series (Carder et al., 1993) were studied. An average of four samples per tumour (range 2-5) were analysed and compared with normal colonic mucosa from the same individual. All samples of all tumours contained stabilised p53 as determined by immunohistocity using PAb 1801 (Oncogene Science). Flow cytometry was performed on frozen tissue and immunohistochemistry was performed on tissue fixed in periodate lysine paraformaldehyde (PLPD), both as described previously. To minimise possible confusion between tumour and non-neoplastic stroma, samples were assessed as diploid only if tumour cels occupied in excess of 50% of tissue sections from which the corresponding flow cytometric analysis showed a diploid main peak. Samples were considered aneuploid if a separate peak, distinct from the diploid peak, was identified, and aneuploid populations from different samples of the same tumour were considered identical unlss they differed in DNA index by more than 0.1. Samples were considred tetraploid if a separate peak with DNA index between 1.9 and 2.1 comprised more than 10% of the nuclei.
Single-strand conformation polymorphism (PCR-SSCP) analysis The polymerase chain reaction (PCR) was performed on 0.1-I Ijg of genomic DNA samples, in an 100 al reaction containing 200 gM of each deoxynucleotide, 50 pmol of each primer and 2 units of a thermostable Taq polymerase in the relevant buffer. PCR was performed in a DNA thermocycler (Hybaid) with the following temperature profile: one cycle of 94'C for 5 min. 30 cycles of 94'C for I min, 58-C for 1 min, 72'C for 1 min, and one cycle of 72 C for 10 min. The primers were as follows (5' to 3'): exon 5 up TTCCTCTTC-CTACAGTAGTC and 5 reverse CGATGGTGAGCAGC-TGGG; exon 6 up CCTCACTGATTGCTCITAGG and 6 reverse CTGAGGTCTGGTTr TGCAACT; exon 7 up TGTGTTATCTCCTAGGTTGG and 7 reverse GTCAG-GAGCCACTTGCCA; exon 8 up TCCTATCCTGAGTAG-TGGT and 8 reverse CGAGGTAAGCAAGCAGGA. The samples were extracted once with 24:1 chloroform/ isoamylalcohol to remove any mineral oil and 5-10gIl was then denatured in 80 giM sodium hydroxide, 10 liM EDTA, at 48°C for 5 min. Two microlitres sequencing stop solution was added, and the whole sample loaded onto a 5% glycerol, 0.5 x MDE Hydrolink gel (Hoefer Scientific). The gel was run in 1 x TBE on the SE400 PAGE apparatus (Hoefer Scientific) at 25°C, 20 W, for 2-3 h.
Normal and tumour samples from the same individual were run together for comparison. Tumour samples were classified as SSCP positive if a discrete additional band was observed. Bands were visualised by a silver stain (BioRad) as per the manufacturer's instructions with additional washes. The gel was dried on to 3MM paper and laminated.
Sequence analysis A total of nine samples from two cases with band shift on SSCP throughout were sequenced by the dideoxy chaintermination technique as described previously (Cripps et al., 1994 ) using a commercial kit (Sequenase, Amersham).
Restriction enzyme digestion using MspI A total of eight samples from two cases with band shift on SSCP throughout and known to contain a CGG-*CAG mutation in codon 248 were analysed by restriction enzyme digestion using MspI. As described previously (Cripps et al., 1994) , disruption of the CCGG recognition site by mutation results in loss of the 135 bp and 168 bp bands and creates an additional 303 bp band.
Results
Seventeen carcinomas which had been sampled at multiple sites and demonstrated immunmohistochemical positivity for PAb 1801, and for which DNA ploidy values were available, were studied. In 14 cases the majority of nuclei stained intensely. Three cases showed the 'mosaic' pattern, in which positive nuclei were scattered sparsely throughout the tumour. Twelve cases contained multiple clonally distinct subpopulations as determined by assessment of DNA ploidy by flow cytometry, with eight containing two and four containing three variant subpopulations.
From each tumour sample exons 5-8 of the p53 gene were amplified individually and analysed by SSCP. Band shifts indicating the presence of a mutant p53 allele with altered conformation were detected by SSCP in 10 of the 17 carcinomas (59%). An average of four samples per tumour were studied, and the same band shift was present in all samples of each SSCP-positive case, suggesting a single clonal mutation event (Figure 1) . The presence of a mutation in the amplified p53 fragment revealing the band shift was confirmed in nine samples of two cases by direct nucleotide sequence analysis. Six samples from one case contained a CGC-*CAC mutation in codon 175 and three samples from the other case contained a CAT-*TAT mutation in codon 179 (Figure 2 ). In two further cases a mutation in codon 248 was confirmed in a total of eight samples using the MspI restriction enzyme digestion technique (Figure 3) . In all, five mutations occurred in exon 5, four in exon 7 and one in exon 8. Six cases with SSCP-confirmed mutations contained multiple divergent populations as detected by assessment of DNA ploidy, indicating clonal evolution subsequent to mutation (Figure 4 ). All samples of the SSCP-negative cases were concordant for absence of band shift, confirming that mutation had not occurred (at any rate in this commonly affected part of the p53 gene) during carcinoma progression in these cases. All cases with mutation demonstrated strong positive staining for PAb 1801 in a majority of tumour cell nuclei, but four cases with similarly strong staining were SSCP negative in exons 5-8. The relationship between immunocytochemistry and mutation is described more fully elsewhere (Cripps et al., 1994) , in a larger number of cases including the present 17. (Glavac and Dean. 1993 (Carder et al.. 1993) . It is interesting that the selective growth advantage afforded by this instability appears to be a feature favouring carcinoma rather than adenoma growth. since p53 mutations are unusual in adenomas. Other lesions involved in colorectal tumorigenesis but unrelated to p53. such as mutation in the DNA repair genes implicated in hereditary non-polyposis colon cancer (Peltomaki et al., 1993) , also initiate genomic instability, albeit of a different type, and associate preferentially with carcinoma rather than adenoma.
In conclusion we establish here by DNA analysis the impression gained from our previous immunohistochemical study: in colorectal tumorigenesis p53 mutation is a critical early lesion occurring as a single clonal mutational event which precedes and probably facilitates the emergence of divergent aneuploid tumour subpopulations.
